Page last updated: 2024-09-02

fingolimod hydrochloride and Hyperoxia

fingolimod hydrochloride has been researched along with Hyperoxia in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bendix, I; Felderhoff-Müser, U; Hadamitzky, M; Hansen, W; Herrmann, R; Herz, J; Heumann, R; Hou, X; Kempe, K; Lumpe, K; Reinboth, BS; Serdar, M; Sifringer, M; Sizonenko, SV; van de Looij, Y	1

Other Studies

1 other study(ies) available for fingolimod hydrochloride and Hyperoxia

Article	Year
Fingolimod protects against neonatal white matter damage and long-term cognitive deficits caused by hyperoxia. Brain, behavior, and immunity, 2016, Volume: 52 Topics: Animals; Animals, Newborn; Brain; Cognition Disorders; Diffusion Magnetic Resonance Imaging; Female; Fingolimod Hydrochloride; Hyperoxia; Lysophospholipids; Male; Microglia; Nerve Fibers, Myelinated; Oligodendroglia; Oxygen; Pregnancy; Random Allocation; Rats; Rats, Wistar; Receptors, Lysosphingolipid; Sphingosine; White Matter	2016

Article

Year

Fingolimod protects against neonatal white matter damage and long-term cognitive deficits caused by hyperoxia.

Brain, behavior, and immunity, 2016, Volume: 52

Topics: Animals; Animals, Newborn; Brain; Cognition Disorders; Diffusion Magnetic Resonance Imaging; Female; Fingolimod Hydrochloride; Hyperoxia; Lysophospholipids; Male; Microglia; Nerve Fibers, Myelinated; Oligodendroglia; Oxygen; Pregnancy; Random Allocation; Rats; Rats, Wistar; Receptors, Lysosphingolipid; Sphingosine; White Matter

2016